| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.0M | -38.9% |
| SG&A Expense | $9.0M | +53.5% |
| Operating Income | -$65.9M | -941.3% |
| Pre-tax Income | $297.0M | +9792.7% |
| Income Tax | $81.3M | +4520.2% |
| Net Income | $215.7M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $31.5M | — |
| Total Assets | $369.9M | +222.4% |
| Current Liabilities | $4.0M | -57.7% |
| Total Liabilities | $117.7M | +657.3% |
| Stockholders' Equity | $252.1M | +1783.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.3M | -1127.1% |
| Capital Expenditures | $19K | -80.7% |
| Investing Cash Flow | -$10.0M | -105.3% |
| Financing Cash Flow | $61.9M | +132.9% |
| Free Cash Flow | -$24.3M | -1069.5% |